These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22490869)

  • 1. NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.
    Meissner TB; Liu YJ; Lee KH; Li A; Biswas A; van Eggermond MC; van den Elsen PJ; Kobayashi KS
    J Immunol; 2012 May; 188(10):4951-8. PubMed ID: 22490869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
    Neerincx A; Rodriguez GM; Steimle V; Kufer TA
    J Immunol; 2012 May; 188(10):4940-50. PubMed ID: 22490867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal NLRC5 regulates MHC class I expression in Neuro-2a cells and also during hippocampal development.
    Li P; Shen Y; Cui P; Hu Y; Zhang Y; Miao F; Zhang A; Zhang J
    J Neurochem; 2020 Jan; 152(2):182-194. PubMed ID: 31549732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
    Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
    Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.
    Meissner TB; Li A; Biswas A; Lee KH; Liu YJ; Bayir E; Iliopoulos D; van den Elsen PJ; Kobayashi KS
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13794-9. PubMed ID: 20639463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
    Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin gene transactivation.
    Gobin SJ; van Zutphen M; Westerheide SD; Boss JM; van den Elsen PJ
    J Immunol; 2001 Nov; 167(9):5175-84. PubMed ID: 11673530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.
    Zhu B; Ouda R; An N; Tanaka T; Kobayashi KS
    J Biol Chem; 2024 May; 300(5):107205. PubMed ID: 38519032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
    J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.
    Neerincx A; Jakobshagen K; Utermöhlen O; Büning H; Steimle V; Kufer TA
    J Immunol; 2014 Sep; 193(6):3090-100. PubMed ID: 25127861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
    Rousseau P; Paul P; O'Brien M; Dausset J; Carosella ED; Moreau P
    Hum Immunol; 2000 Nov; 61(11):1132-7. PubMed ID: 11137218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.